Identifying MASLD patient eligibility for pharmacological therapy: the need to integrate evidence into clinical practice

Nature Reviews Gastroenterology and Hepatology · Published 2026-05-20 · DOI 10.1038/s41575-026-01214-8

Authors (2)

Javier Ampuero, Manuel Romero-Gomez

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ampuero, J., Romero-Gomez, M. (2026). Identifying MASLD patient eligibility for pharmacological therapy: the need to integrate evidence into clinical practice. Nature Reviews Gastroenterology and Hepatology. https://doi.org/10.1038/s41575-026-01214-8

Related articles